18F-FDG PET/CT for invasive fungal infection in immunocompromised patients.
Fiche publication
Date publication
juin 2018
Journal
QJM : monthly journal of the Association of Physicians
Auteurs
Membres identifiés du Cancéropôle Est :
Pr HERBRECHT Raoul
Tous les auteurs :
Leroy-Freschini B, Treglia G, Argemi X, Bund C, Kessler R, Herbrecht R, Imperiale A
Lien Pubmed
Résumé
Opportunistic invasive fungal infections (IFIs) comprise a heterogeneous spectrum of pathogens, whose early diagnosis remains challenging. Candida spp. and Aspergillus spp, the most frequent pathogens in immunocompromised patients, frequently affect lungs, liver, bone and skin.
Mots clés
Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Female, Fluorodeoxyglucose F18, administration & dosage, Humans, Immunocompromised Host, Invasive Fungal Infections, diagnostic imaging, Male, Middle Aged, Positron Emission Tomography Computed Tomography, Radiopharmaceuticals, administration & dosage, Retrospective Studies, Sensitivity and Specificity, Young Adult
Référence
QJM. 2018 Jun 18;: